Axsome Therapeutics (AXSM) Property, Plant & Equipment (Net) (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.89% |
| Dec 31, 2025 | -7.11% |
| Sep 30, 2025 | -9.30% |
| Jun 30, 2025 | -13.71% |
| Mar 31, 2025 | 32.36% |
| Dec 31, 2024 | -14.49% |
| Sep 30, 2024 | -5.66% |
| Jun 30, 2024 | -10.84% |
| Mar 31, 2024 | -4.02% |
| Dec 31, 2023 | -12.87% |
| Sep 30, 2023 | 31.93% |
| Jun 30, 2023 | 4.69% |
| Mar 31, 2023 | -2.63% |
| Dec 31, 2022 | 15.15% |
| Sep 30, 2022 | -1.20% |
| Jun 30, 2022 | 37.68% |
| Mar 31, 2022 | 62.39% |
| Dec 31, 2021 | -9.86% |
| Sep 30, 2021 | 277.37% |
| Jun 30, 2021 | 12.28% |
| Mar 31, 2021 | 41.16% |
| Dec 31, 2020 | 32.46% |
| Sep 30, 2020 | 30.65% |
| Jun 30, 2020 | -11.87% |
| Mar 31, 2020 | 12.72% |
| Dec 31, 2019 | -11.38% |
| Sep 30, 2019 | -15.20% |
| Jun 30, 2019 | 0.88% |
| Mar 31, 2019 | -22.07% |
| Dec 31, 2018 | -19.06% |
| Sep 30, 2018 | -6.70% |
| Jun 30, 2018 | -2.93% |
| Mar 31, 2018 | 3.88% |
| Dec 31, 2017 | -14.21% |
| Sep 30, 2017 | -8.30% |
| Jun 30, 2017 | -7.48% |
| Mar 31, 2017 | -7.16% |
| Dec 31, 2016 | -3.54% |
| Sep 30, 2016 | 209.04% |
| Jun 30, 2016 | 34.13% |
| Mar 31, 2016 | 51.28% |